Abstract
CD95 expression on peripheral blood lymphocytes in patients with neoplasms was higher than in patients with autoimmune disorders. Apoptosis of T cells increased during tumor growth. The data suggest that neoplasms are accompanied by more severe immune dysfunction than autoimmune disorders.
Similar content being viewed by others
References
S. G. Abbasova, N. E. Kushlinskii, A. N. Murashev,et al., Byull. Eksp. Biol. Med.,127, No. 3, 328–331 (1999).
P. S. Barban, R. A. Pshenichnov, A. N. Pantyukhina, and I. B. Ivshina,Immunofluorescent Assay [in Russian], Sverdlovsk (1988).
A. Yu. Baryshnikov, E. R. Polosukhina, T. N. Zabotina,et al., Ros. Zh. Immunol.,2, No. 2, 115–120 (1997).
L. N. Bubnova, T. V. Glazanova, T. S. Zubareva,et al., Med. Immunol.,1, No. 3-4, 50–51 (1999).
Z. G. Kadagidze,Vestn. Ros. Akad. Med. Nauk, No. 5, 19–22 (1999).
G. Cardi, J. A. Heany, A. R. Schned, and M. S. Ernstoff,Cancer Res.,58, No. 10, 2078–2080 (1998).
T. Kotani, Y. Aratake, and S. Ohtaki,Rinsho Byori,45, No. 11, 1038–1047 (1997).
H. Ohashi and N. Ogawa,Nippon Rinsho,53, No. 10, 2451–2455 (1995).
W. Schroder, A. Vering, M. Stegmuller, and R. Strohmeier,Eur. J. Gynaecol. Oncol.,18, No. 6, 474–477 (1997).
T. L. Whiteside and H. Rabinowich,Cancer Immunol.Immunother.,46, 175–184 (1998).
L. E. Van den Hove, P. Vandenberghe, S. W. Van Gool,et al., Leuk. Res.,22, No. 2, 175–184 (1998).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 130, No. 9, pp. 324–326, September, 2000
Rights and permissions
About this article
Cite this article
Oleinik, E.K., Shibaev, M.I. Expression of CD95 on peripheral blood lymphocytes in patients with autoimmune diseases and neoplasms. Bull Exp Biol Med 130, 892–894 (2000). https://doi.org/10.1023/A:1015378631731
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1023/A:1015378631731